SIRIO(SZ:300791) Guohai Securities·2025-09-01 14:30Investment Rating - The investment rating for the company is "Buy" (maintained) [1][10][11] Core Insights - The company has successfully expanded its new consumer client base, with strong performance in the Americas and Europe [3][7] - In H1 2025, the company achieved revenue of 2.04 billion yuan, a year-on-year increase of 2.6%, and a net profit attributable to shareholders of 160 million yuan, up 4.3% year-on-year [6][7] - The company is positioned as a leading CDMO in the health supplement industry, with a focus on innovation and technology upgrades [10] Summary by Sections Recent Performance - In H1 2025, the company reported revenue of 2.04 billion yuan, with a net profit of 160 million yuan, and a non-recurring net profit of 160 million yuan [6][7] - Q2 2025 revenue was 1.09 billion yuan, a 4.7% increase year-on-year, with a net profit of 90 million yuan, up 1.1% year-on-year [6][7] Regional Performance - China region revenue in H1 2025 was 820 million yuan, down 1.6% year-on-year, affected by the long-term market [7] - The Americas region saw revenue of 760 million yuan, a 4.3% increase year-on-year, with exports maintaining positive growth despite tariff disruptions [7] - The European region achieved revenue of 360 million yuan, a significant 22.0% increase year-on-year, exceeding sales targets [7] Profitability and Cost Management - The company's gross margin improved by 1.13 percentage points to 33.2% in H1 2025, attributed to lean production and cost reduction efforts [7] - In Q2 2025, the gross margin was slightly down by 0.1 percentage points to 33.3% due to disruptions in the BF business [7] Future Outlook - The company anticipates a stable recovery in domestic business revenue and continued growth in new consumer markets, with plans to expand into high-potential sectors like pet nutrition [7][10] - The forecast for revenue from 2025 to 2027 is 44.92 billion yuan, 51.04 billion yuan, and 58.63 billion yuan respectively, with net profits projected at 350 million yuan, 460 million yuan, and 570 million yuan [10][11]